Hippocampus Proteomics and Brain Lipidomics Reveal Network Dysfunction and Lipid Molecular Abnormalities in APP/PS1 Mouse Model of Alzheimer's Disease.

Journal of Proteome Research
Xueju ZhangWen Tan

Abstract

Alzheimer's disease (AD) is closely associated with protein dysfunction and aberrant lipid metabolism in the brain. Our study could be conducive to the discovery of lipid and protein biomarkers for early diagnosis and therapy. In our current work, novel quantitative proteomic and lipidomic methods were developed for the characterization of molecular perturbation occurring in the brain in early stage AD mice. For this purpose, we performed a proteomic and lipidomic screening by liquid chromatography with mass spectrometry. Significant changes were detected, including 231 proteins and 11 lipid compounds in the AD mouse brain. Early stage AD disturbed biological pathways implicated in neuroactive ligand-receptor, complement and coagulation cascades, PI3K-Akt signaling and metabolic pathways, and glycerophospholipid metabolism. The results in the current study suggest that these significantly altered proteins and lipids may be implicated in early stage AD. Our work raises the possibility of AD diagnosis and therapy by providing new protein targets and lipid biomarkers.

References

May 5, 2001·Biomolecular Engineering·J L JankowskyD R Borchelt
Apr 17, 2003·Proceedings of the National Academy of Sciences of the United States of America·John F ReillyFloyd E Bloom
Mar 4, 2011·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Carola RombergLisa M Saksida
Sep 11, 2012·Biochimica Et Biophysica Acta·Jean E Vance, Guergana Tasseva
Jul 3, 2013·Biochimica Et Biophysica Acta·Eugenia Trushina, Michelle M Mielke
Jul 25, 2013·Frontiers in Physiology·Steffany A L BennettDaniel Figeys
Jan 30, 2014·Journal of Proteomics·Raúl González-DomínguezJosé Luis Gómez-Ariza
Jul 6, 2014·Progress in Lipid Research·Hee-Yong KimArthur A Spector
Dec 3, 2014·Journal of Pharmaceutical and Biomedical Analysis·Raúl González-DomínguezJosé Luis Gómez-Ariza
Jul 15, 2015·Evidence-based Complementary and Alternative Medicine : ECAM·Liping YangXuekun Song
Jan 17, 2016·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·David C HondiusAugust B Smit
Feb 2, 2016·Neurobiology of Aging·Xiaobei PanBrian D Green
Feb 21, 2016·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·Hang ChuXijun Wang
Mar 16, 2016·Data in Brief·Jane A EnglishDavid R Cotter
Oct 30, 2016·Rapid Communications in Mass Spectrometry : RCM·Mao-Wei NiZhi-Guo Zheng
Dec 3, 2016·Journal of Alzheimer's Disease : JAD·Liming ShenJiazuan Ni
May 13, 2017·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Weiwei LinXiaomei Ling
Jun 21, 2017·Neurobiology of Disease·Shahar BarbashHermona Soreq
Nov 23, 2017·Analytical Chemistry·Yepy H Rustam, Gavin E Reid
Jan 3, 2018·Nature·Carmen VenegasMichael T Heneka
Feb 10, 2018·Translational Neurodegeneration·Xiaoguang DuMeiyu Geng
Mar 15, 2018·Biochemical and Biophysical Research Communications·Hyeon-Cheol Lee, Takehiko Yokomizo
Mar 30, 2018·Biochemical and Biophysical Research Communications·Paul L Wood, John E Cebak
Dec 7, 2018·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Feng XiongChao Ma
Jul 6, 2019·Frontiers in Neuroscience·Sami GabboujTeemu Natunen

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Coagulation Signaling Pathways

Coagulation is the process by which a blood clot is formed. This process includes both the formation of a platelet plug as well as a cascade of clotting factors resulting in the formation of fibrin strands. Find the latest research on coagulation signaling pathways here.

Alzheimer's Disease: Animal Models

Alzheimer's disease is a neurodegenerative disease which can be studied using various experimental systems. This feed focuses on animal models used for Alzheimer's disease research.

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.